The Feasibility of Sugammadex for General Anesthesia in Patients Undergoing Kidney and Pancreas Transplantation Surgery

• Status: Completed
• Trial end date: 2021-04-21
• Target enrollment: 0
• Participant gender: All

Summary

The effectiveness and safety of sugammadex were confirmed in pancreas kidney transplatation patients for reversal of deep neuromuscular blockade induced by rocuronium.Sugmmadex can reduce the length of PACU stay.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Second Affiliated Hospital of Guangzhou Medical University

Criteria

Inclusion Criteria:

1. age between 25 and 62 years

2. body mass index （BMI）of 18.5-24.9kg/m2

3. American Society of Anesthesiologists (ASA) score from I to III.

Exclusion Criteria:

1. history of allergy to narcotic drugs and other drugs

2. cardiopulmonary insufficiency

3. congestive heart failure

4. neuromuscular disease，such as myasthenia gravis

5. severe liver dysfunction

6. hyperkalemia

7. history of malignant hyperfever .